UF scientist develops safer gene therapy restoring vision in children with rare inherited eye diseases; pivotal trials begin ...
One night, Tomás realized something was seriously wrong. He went for a stroll, along the same paths near his village that he ...
Discusses Proposed Acquisition of Apellis and Strategic Growth Objectives March 31, 2026 8:30 AM EDTCompany ParticipantsTim Power - ...
Low vision is significant sight loss not fully correctable by standard treatments It differs from blindness as some usable vision remains for daily activities Causes include macular degeneration, ...
Patients must undergo hematopoietic stem cell mobilization followed by apheresis to obtain CD34+ cells for Kresladi manufacturing. The Food and Drug Administration (FDA) has granted accelerated ...
An Ultragenyx gene therapy has scored a win at the midway point of its phase 3 trial, successfully reducing ammonia levels in patients with a rare urea cycle disorder. Thirty-six weeks after one-time ...
Hosted on MSN
Blindness banished! Gene therapy unlocks sight, transforms lives in London breakthrough!
What if the darkness that enveloped a child's world suddenly… vanished? What if hope, once a whisper, roared into life with a single, breathtaking breakthrough? In the heart of London, a team of ...
Smoking or living with cigarette smoke can accelerate age-related degeneration of the eyes, researchers from Johns Hopkins Medicine found, and it hurts young eyes more. "Smoking is often assumed to ...
RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results